Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Salmeterol (25mcg) + Fluticasone Propionate (500mcg)
Therapeutic Category
Pulmonary, Respiratory, Asthma
Dosage Form
Inhaler
Packaging Type
Metered Dose with Carton and Leaflet
Packaging
120 Metered Dose
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Flutialfa S 500 Inhaler combines Salmeterol (25mcg) and Fluticasone Propionate (500mcg), making it a highly effective treatment for individuals with chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Salmeterol is a long-acting beta-agonist (LABA), which works by relaxing the muscles in the airways and allowing them to open up, making it easier to breathe. Fluticasone Propionate is a corticosteroid that reduces inflammation in the airways, thus preventing symptoms such as wheezing, shortness of breath, and coughing.
This combination works synergistically to not only relieve the symptoms of asthma and COPD but also to prevent exacerbations and improve overall lung function. Flutialfa S 500 is particularly beneficial for patients who require both a long-acting bronchodilator and an anti-inflammatory to manage their respiratory condition effectively.
Common side effects may include headache, throat irritation, cough, oral thrush, or hoarseness. Rarely, it may cause increased heart rate, tremors, or nervousness. If any severe allergic reactions or breathing difficulties occur, immediate medical attention is required.
Flutialfa S 500 Inhaler is indicated for the maintenance treatment of asthma and COPD to prevent bronchospasm and reduce inflammation.
Consult your doctor before use if you have a history of heart disease, high blood pressure, or other respiratory conditions. Do not exceed the recommended dose.
Store in a cool, dry place at room temperature. Keep the inhaler away from direct sunlight and moisture. Keep out of reach of children.
Composition : Salmeterol (25mcg) + Fluticasone Propionate (250mcg)
Composition : Ambroxol (10mg/5ml) + Guaifenesin (25mg/5ml) + Terbutaline (0.5mg/5ml)
Composition : Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Menthol (2.5mg/5ml) + Terbutaline (1.25mg/5ml)
Composition : Chlorpheniramine Maleate (2mg/5ml) + Levodropropizine (30mg/5ml)
Composition : Ambroxol (7.5mg) + Levosalbutamol (0.25mg) + Guaifenesin (12.5mg)
Composition : Ambroxol (7.5mg) + Guaifenesin (12.5mg) + Terbutaline (0.25mg)
Composition : Acebrophylline (100mg) + Acetylcysteine (600mg)
Composition : Acebrophylline (200mg) tablet
Composition : Acetylcysteine (600mg) effervescent
Composition : Ambroxol (15mg) + Guaifenesin (50mg) + Phenylephrine (5mg) + Paracetamol (325mg) + Cetirizine (5mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Salmeterol 25mcg + Fluticasone Propionate 50mcg Inhaler has strong demand in the respiratory care, pulmonology, and chronic disease management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on asthma and COPD care portfolios.
Medical distributors and agencies can benefit from consistent demand for chronic respiratory disease management under medical supervision. Salmeterol 25mcg is a long-acting bronchodilator (LABA) that helps keep airways open for an extended period Fluticasone Propionate 50mcg is an inhaled corticosteroid that helps reduce airway inflammation Commonly prescribed for asthma and chronic obstructive pulmonary disease (COPD) as part of long-term maintenance therapy Helps improve breathing, reduce respiratory symptoms, and decrease the frequency of disease exacerbations Inhaler formulation delivers medication directly to the lungs for targeted therapeutic action Widely prescribed by pulmonologists, chest physicians, allergists, and general practitioners This strengthens a comprehensive respiratory care and pulmonology portfolio
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Salmeterol 25mcg + Fluticasone Propionate 50mcg Inhaler with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong demand in respiratory care, long-term therapy usage, repeat prescriptions, reliable supply chain support, and attractive margins in the pulmonology segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.